Columbia cancer researchers are investigating how exercise, early puberty, and hormones may play a role in the rising numbers of early onset breast cancer.
In the same way that ChatGPT understands human language, a new AI model developed by Columbia computational biologists captures the language of cells to accurately predict their activities.
By generating movies of individual molecules performing actions that make our bodies tick, Columbia researchers have a deeper understanding of a process important in cancer and other diseases.
Columbia’s Dian Yang is placing CRISPR-based molecular recorders into cancer cells to eavesdrop on cancer evolution and pinpoint when and how cells metastasize.
Richard D. Carvajal, MD, has been named director of the Experimental Therapeutics/Phase I program and melanoma service in medical oncology at NewYork-Presbyterian/Columbia University Medical Center, effective Nov. 1, 2014.
Daniel Seidman, author of “Smoke-Free in 30 Days,” will participate in a blogtalkradio show Nov. 17 in advance of this year’s Great American Smokeout on Nov. 20.
A CUMC study found that the use of generic aromatase inhibitors, which cost considerably less than their brand-name counterparts, increased treatment adherence by 50 percent.
Using an innovative algorithm, CUMC researchers have found that loss of a gene called KLHL9 is the driving force behind the most aggressive form of glioblastoma, the most common form of brain cancer.
The Herbert Irving Comprehensive Cancer Center is one of only two NCI-designated Comprehensive Cancer Centers in New York City and one of only three in New York State.
Research from Columbia shows that nerves play a critical role in stomach cancer growth and blocking nerve signals using surgery or Botox® could provide an effective therapy for the disease.